TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Pharmaq Analytiq AS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
55,776
|
57,514
|
55,623 |
| Financial expenses |
226
|
361
|
343 |
| Earnings before taxes |
-3,323
|
-464
|
-4,506 |
| Total assets |
28,841
|
26,785
|
35,523 |
| Current assets |
16,395
|
12,513
|
18,907 |
| Current liabilities |
15,413
|
13,163
|
20,488 |
| Equity capital |
13,182
|
13,477
|
14,738 |
| - share capital |
693
|
729
|
777 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
45.7%
|
50.3%
|
41.5% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-6.0%
|
-0.8%
|
-8.1% |
| Return on assets (ROA) |
-10.7%
|
-0.4%
|
-11.7% |
| Current ratio |
106.4%
|
95.1%
|
92.3% |
| Return on equity (ROE) |
-25.2%
|
-3.4%
|
-30.6% |
| Change turnover |
1,150
|
5,308
|
-2,732 |
| Change turnover % |
2%
|
10%
|
-5% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.